Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Highlow: LMWH Dosing for Recurrent VTE Prevention in Pregnancy
NCT01828697Phase 4Completed
- Sponsor
- University of Amsterdam
- Start
- Apr 2013
- Primary completion
- Oct 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 10
01
Overview
A Phase 4 trial of low molecular weight heparin calcium in venous thromboembolism (VTE), sponsored by University of Amsterdam. Started Apr 2013; status: completed.
02
Drugs
low molecular weight heparin calcium
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT01828697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01828697.